5 mins read

Sepsis Diagnostics Market Analysis, Growth, Demand, Trends and Forecast Till 2028

IMARC Group, a leading market research company, has recently releases report titled “Sepsis Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global sepsis diagnostics market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

How big is the sepsis diagnostics market?

The global sepsis diagnostics market size reached US$ 631 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,052 Million by 2028, exhibiting a growth rate (CAGR) of 8.9% during 2023-2028.

Request for a sample report or buy full report: https://www.imarcgroup.com/sepsis-diagnostics-market/requestsample

What are sepsis diagnostics?

Sepsis diagnostics refers to the methods and tools used to detect sepsis, a life-threatening condition caused by the body’s extreme response to an infection. Early and accurate diagnosis of sepsis is crucial, as timely intervention can significantly improve patient outcomes. Sepsis diagnostics involves various laboratory tests, including blood cultures, biomarker assays, and imaging studies. Sepsis diagnostics remains a vital area of focus in critical care, contributing to efforts to reduce mortality and morbidity associated with this complex condition.

What are the growth prospects and trends in the industry?

Innovations in molecular diagnostics, point-of-care testing, and biomarker identification are enhancing the speed and precision of sepsis diagnosis which represents one of the key factors driving the growth of the market across the globe. With increased cases of sepsis globally, there is a heightened need for accurate and timely diagnosis, which is driving the demand for advanced diagnostics. The increasing investments in healthcare facilities and equipment are facilitating the adoption of sophisticated diagnostic techniques. The market is also driven by government support in the form of funding, guidelines, and awareness campaigns which is boosting the emphasis on early sepsis detection. In addition to this, medical communities and organizations are working to raise awareness about sepsis, its risks, and the importance of prompt diagnosis and treatment. Favorable reimbursement scenarios in certain regions encourage the utilization of advanced sepsis diagnostic methods. The ongoing battle against infections, including those resistant to antibiotics, places sepsis as a central concern, which is creating a positive outlook for the market across the globe.

Competitive Landscape With Key Players:

The competitive landscape of the sepsis diagnostics market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

  • Abbott Laboratories
  • Becton, Dickinson and Company (BD)
  • biomerieux SA
  • Bruker Corporation
  • EKF Diagnostics Holding Plc
  • Epic Systems Corporation
  • Luminex Corporation
  • Roche Holding AG
  • Sysmex Corporation
  • T2 Biosystems Inc.

 Key Market Segmentation:

The report has segmented the global sepsis diagnostics market based on diagnosis, product, mode of testing, technology, pathogen, end-user and region.

Breakup by Diagnosis:

  • Automated Diagnostics
  • Conventional Diagnostics

Breakup by Product:

  • Instruments
  • Assay Kits and Reagents
  • Blood Culture Media
  • Software

Breakup by Mode of Testing:

  • Laboratory Tests
  • Point-of-Care Tests

Breakup by Technology:

  • Molecular Diagnostics
  • Immunoassays
  • Biomarkers
  • Flow Cytometry
  • Microfluidics
  • Blood Culture

Breakup by Pathogen:

  • Bacterial Sepsis
    • Gram-Positive Bacterial Sepsis
    • Gram-Negative Bacterial Sepsis
  • Viral Sepsis
  • Fungal Sepsis
  • Others

Breakup by End User:

  • Diagnostic Clinics
  • Hospitals
  • Research Laboratories

Breakup by Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=3090&flag=C

 Key Highlights of the Report:

  • Market Performance (2017-2022)
  • Market Outlook (2023-2028)
  • Market Trends
  • Market Drivers and Success Factors
  • Impact of COVID-19
  • Value Chain Analysis
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: https://twitter.com/ImarcServices

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/

Leave a Reply

Your email address will not be published. Required fields are marked *